Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Centrum Medyczne ENEL-MEDWAR:ENE -2.50%77 EV-to-EBIT is 30.66 as of Aug. 14, 2026, which is 16% below its 10-year median of 36.70. GuruFocus rates WAR:ENE with a GF Score™ of 77/100 and a GF Value™ of zł25.53 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 472 Healthcare Providers & Services companies, Centrum Medyczne ENEL-MED ranks worse than 79.03% on this metric.
The historical rank and industry rank for Centrum Medyczne ENEL-MED's EV-to-EBIT or its related term are showing as below:
WAR:ENE'
s EV-to-EBIT Range Over the Past 10 Years
Min: -604.93 Med: 36.7 Max: 357.88
Current: 30.66
During the past 13 years, the highest EV-to-EBIT of Centrum Medyczne ENEL-MED was 357.88. The lowest was -604.93. And the median was 36.70.
WAR:ENE's EV-to-EBIT is ranked worse than 79.03% of 472
companies
in the Healthcare Providers & Services industry
Industry Median: 15.715
vs WAR:ENE: 30.66
Centrum Medyczne ENEL-MED (WAR:ENE) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Centrum Medyczne ENEL-MED's Enterprise Value for the quarter that ended in Mar. 2026 was zł846.2 Mil.
Centrum Medyczne ENEL-MED's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł28.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Centrum Medyczne ENEL-MED EV-to-EBIT Related Terms
Centrum Medyczne ENEL-MED EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centrum Medyczne ENEL-MED EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Centrum Medyczne ENEL-MED's EV-to-EBIT falls into.
Centrum Medyczne ENEL-MED's current Enterprise Value is zł857.5 Mil.
Centrum Medyczne ENEL-MED's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł28.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Centrum Medyczne ENEL-MED (WAR:ENE) has a EV-to-EBIT of 30.66 as of Aug. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Centrum Medyczne ENEL-MED and its competitors. This is 16% below median its historical median of 36.70. According to the industry distribution chart, Centrum Medyczne ENEL-MED ranks #373 out of 472 companies in the Healthcare Providers & Services industry, placing it in the top 79%.
Is Centrum Medyczne ENEL-MED's EV-to-EBIT too high?
Centrum Medyczne ENEL-MED's current EV-to-EBIT of 30.66 is 16% below median its 10-year median of 36.70. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. Centrum Medyczne ENEL-MED's value of 30.66 is 95.1% above this industry median. Based on the distribution chart, Centrum Medyczne ENEL-MED ranks #373 out of 472 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Centrum Medyczne ENEL-MED ranks #373 out of 472 companies for EV-to-EBIT. This places Centrum Medyczne ENEL-MED in the lower half of its industry. The industry median EV-to-EBIT is 15.72. Centrum Medyczne ENEL-MED's value of 30.66 is 95.1% above this benchmark. While the company's 10-year median is 36.70 vs. the industry median of 15.72, Centrum Medyczne ENEL-MED has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centrum Medyczne ENEL-MED's current EV-to-EBIT of 30.66 is 95.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Centrum Medyczne ENEL-MED and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centrum Medyczne ENEL-MED's current EV-to-EBIT is 30.66, which is 16% below median its own 10-year median of 36.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł25.53, compared to a current price of zł19.50 — trading 23.6% below its estimated fair value. The current EV-to-EBIT is 30.66, which is 16% below median its 10-year median of 36.70 and 95.1% above the Healthcare Providers & Services industry median of 15.72. Centrum Medyczne ENEL-MED's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current EV-to-EBIT is 30.66 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued.
The current stock price of zł19.50 is trading 23.6% below its estimated GF Value™ of zł25.53.
GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.
Key valuation signals for WAR:ENE:
EV-to-EBIT: 30.66 (16% below median its 10-year median of 36.70)
GF Value™: zł25.53 vs. price of zł19.50 (23.6% below fair value)
Industry Position: 95.1% above the Healthcare Providers & Services median (#373 of 472)
No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
77GF Score
Get the complete analysis for WAR:ENE
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ENE has been successfully added to your 
